Multimodality approaches for pancreatic cancer

Gary Y. Yang, Timothy D. Wagner, Martin Fuss, Charles R. Thomas

Resultado de la investigación: Review articlerevisión exhaustiva

29 Citas (Scopus)


The role of combined-modality therapy for pancreatic cancer is evolving with the recent development and completion of major, multi-institutional clinical trials. One of the challenges for the busy clinician is to appreciate the variation in staging, surgical expertise, and application of either definitive chemoradiotherapy or adjuvant chemoradiotherapy for local and/or regionally advanced disease. Our aim is to summarize the current state-of-the-art management and future directions regarding the multimodality approach to pancreatic cancer.

Idioma originalEnglish (US)
Páginas (desde-hasta)352-367
Número de páginas16
PublicaciónCa-A Cancer Journal for Clinicians
EstadoPublished - 2005
Publicado de forma externa

ASJC Scopus subject areas

  • Hematology
  • Oncology


Profundice en los temas de investigación de 'Multimodality approaches for pancreatic cancer'. En conjunto forman una huella única.

Citar esto